Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 PW Medtec went public in HK stock market
CreateTime:2013-11-14 Editor:liaoyan
Text Size:       

PW Medtech Group Limited (stock code: 1358), a leading medical device company in China, today announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited. PW Medtech plans to offer an aggregate of 400,000,000 shares to raise net proceeds of approximately HK$1,118.5 million.

PW Medtech is a leading medical device company in China focused on high-growth, high-margin and large market capacity segments in the medical device industry. The core business of the Group is orthopedic implants and advanced infusion sets, which are both at the forefront of the China medical market. 

The Group has delivered strong financial performance with the orthopedic implants and infusion sets businesses. Its revenue grew to RMB331.5 million in 2012, or at a CAGR of 133.5% from 2010 to 2012. Net profit grew to RMB100.2 million in 2012, representing a CAGR of 164.4% from 2010 to 2012. Total revenue increased by 50.1% from RMB145.8 million in the six months ended June 30, 2012 to RMB218.8 million in the same period in 2013, reflecting an increase in revenue from both the orthopedic implant and infusion set businesses. 

Related Reports
China Blood Product Industry Report, 2020-2027
China Medical Robot Industry Report, 2020-2026
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
China Aged Care Industry Report, 2019-2025
China Dental Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1